相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adaptive dose-response studies to establish proof-of-concept in learning-phase clinical trials
Shiyang Ma et al.
BIOMETRICAL JOURNAL (2022)
POS-546 EFFICACY AND SAFETY OF IPTACOPAN IN IgA NEPHROPATHY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 STUDY AT 6 MONTHS
J. Barratt et al.
Kidney International Reports (2022)
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
Bengt C. Fellstroem et al.
LANCET (2017)
Bayesian Design of Proof-of-Concept Trials
Roland Fisch et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2015)
When is a seamless study desirable? Case studies from different pharmaceutical sponsors
Robert L. Cuffe et al.
PHARMACEUTICAL STATISTICS (2014)
Model-based dose finding under model uncertainty using general parametric models
Jose Pinheiro et al.
STATISTICS IN MEDICINE (2014)
Two-stage designs for Phase 2 dose-finding trials
Anastasia Ivanova et al.
STATISTICS IN MEDICINE (2012)
Adaptive and Model-Based Dose-Ranging Trials: Quantitative Evaluation and Recommendations. White Paper of the PhRMA Working Group on Adaptive Dose-Ranging Studies
Jose Pinheiro et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2010)
Adaptive dose finding based on t-statistic for dose-response trials
Anastasia Ivanova et al.
STATISTICS IN MEDICINE (2008)
Operational challenges in adaptive design implementation
P Gallo
PHARMACEUTICAL STATISTICS (2006)
Combining multiple comparisons and modeling techniques in dose-response studies
F Bretz et al.
BIOMETRICS (2005)
分享论文
